Silgan Declares Quarterly Dividend
Get Alerts SLGN Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2%
Revenue Growth %: +4.5%
Join SI Premium – FREE
NORWALK, Conn.--(BUSINESS WIRE)-- Silgan Holdings Inc. (NYSE: SLGN), a leading supplier of sustainable rigid packaging solutions for the world's essential consumer goods products, announced today that its Board of Directors declared a quarterly cash dividend on its common stock. The Board of Directors approved a $0.20 per share quarterly cash dividend payable on September 16, 2025 to the holders of record of common stock of the Company on September 2, 2025. With this dividend payment, the Company will have paid a quarterly cash dividend on its common stock, which it has increased every year, for eighty-six consecutive quarters since 2004.
Silgan is a leading supplier of sustainable rigid packaging solutions for the world's essential consumer goods products with annual net sales of approximately $5.9 billion in 2024. Silgan operates 124 manufacturing facilities in North and South America, Europe and Asia. The Company is a leading worldwide supplier of dispensing and specialty closures for fragrance and beauty, food, beverage, personal and health care, home care and lawn and garden products. The Company is also a leading supplier of metal containers in North America and Europe for pet and human food and general line products. In addition, the Company is a leading supplier of custom containers for shelf-stable food and personal care products in North America.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250805920130/en/
Alexander Hutter
Vice President, Investor Relations
[email protected]
203-406-3187
Source: Silgan Holdings Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Travere Presents New Biomarker Data at ASN Kidney Week Suggesting FILSPARI® (sparsentan) May Modify Underlying Disease Pathophysiology in IgA Nephropathy
- Pathalys Pharma Presents Positive Data from Pivotal Phase 3 Studies of Upacicalcet in Featured Oral Presentation at ASN Kidney Week 2026
- Principal Real Estate Income Fund Announces Changes in Portfolio Management
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share